Intranasal corticosteroid sprays are the single most effective everyday treatment for nasal allergies, outperforming oral antihistamines across nearly every symptom measure in head-to-head trials. But “best” depends on what kind of allergy you have, how severe it is, and whether you want quick relief or a long-term fix. The treatment landscape ranges from cheap over-the-counter pills to injectable biologics that cost tens of thousands of dollars a year, and the evidence behind each option varies widely.
Intranasal Corticosteroids Top the Rankings
If you deal with a stuffy, runny, itchy nose during allergy season or year-round, a steroid nasal spray like fluticasone, mometasone, or budesonide is the treatment with the strongest evidence behind it. A 2024 systematic review and meta-analysis found that intranasal corticosteroids beat oral antihistamines at improving total nasal symptoms, eye symptoms, and overall quality of life, with most of those improvements crossing the threshold for what patients actually notice in daily life.
An earlier meta-analysis published in 2016 reached a similar verdict, finding intranasal steroids superior for total nasal symptoms, congestion, sneezing, and nasal itching compared to oral antihistamines.
The reason steroid sprays work so well is that they target inflammation right where it starts, in the nasal lining, rather than just blocking histamine the way an antihistamine does. Congestion in particular responds much better to steroids than to antihistamines, which is why many people find that a daily pill leaves them still stuffy even when their sneezing improves. The catch is that steroid sprays take a few days of regular use to reach full effect, so they are not the best choice when you need relief in the next half hour.
Second-Generation Oral Antihistamines
Pills like cetirizine, loratadine, fexofenadine, desloratadine, and levocetirizine remain the most popular allergy treatment worldwide, largely because they are cheap, available everywhere, and easy to take. They work well for sneezing, itching, and a runny nose, though they are less effective than nasal steroids for congestion.
The key distinction within the antihistamine class is generational. Older first-generation antihistamines like diphenhydramine (Benadryl) and chlorpheniramine readily cross into the brain, causing drowsiness and impairing thinking, memory, and reaction time. In a comparative trial, people taking diphenhydramine showed measurable deficits in divided attention, working memory, and speed, while those on loratadine performed no differently from people on placebo.
Second-generation antihistamines were specifically designed to stay out of the brain, and they largely succeed. They cause little to no sedation at standard doses. For that reason, allergy guidelines universally recommend second-generation options over first-generation ones for routine use. The older drugs still have a role in acute allergic reactions and as sleep aids, but for daily allergy control they create more problems than they solve.
How Quickly Treatments Kick In
When pollen counts spike or you walk into a house with a cat, you want something that works fast. Intranasal antihistamine sprays like azelastine have a clear advantage here. In a controlled allergen-exposure study, azelastine nasal spray began reducing symptoms within 15 minutes, while oral cetirizine took about an hour and oral loratadine took roughly 75 minutes. A separate study comparing azelastine to oral desloratadine found an even wider gap, with azelastine working in 15 minutes versus about two and a half hours for desloratadine.
This speed difference matters in practice. If you know your triggers and can plan ahead, a daily oral antihistamine or nasal steroid works fine because you take it before symptoms start. But for unpredictable exposures, having an intranasal antihistamine on hand gives you the fastest non-injection option available. Some people keep both a daily steroid spray and an as-needed azelastine spray in their medicine cabinet, which covers both the prevention and rescue scenarios.
Combination Nasal Sprays
Products that pair a steroid with a nasal antihistamine in one bottle, like fluticasone plus azelastine (sold as Dymista), are often marketed as the ultimate nasal allergy treatment. The logic is sound: you get the fast-acting antihistamine alongside the deeper anti-inflammatory steroid. In adults with moderate-to-severe allergic rhinitis, combination sprays have generally shown benefits over either ingredient alone.
The picture is less clear-cut in children. A recent pediatric study comparing the combination of fluticasone and azelastine to fluticasone alone found no meaningful difference in nasal symptom scores or quality of life between the two groups. This doesn’t mean the combination is useless in kids, but it does suggest that the steroid component is doing the heavy lifting and adding the antihistamine may not always justify the added cost. For adults with stubborn symptoms that don’t fully respond to a steroid spray on its own, the combination remains a reasonable step up.
Saline Nasal Irrigation
Rinsing your nose with salt water is one of the simplest and cheapest things you can do for allergies, and the evidence supporting it is surprisingly strong. A Cochrane review found that regular saline irrigation produced large improvements in patient-reported symptom severity at both four weeks and three months compared to doing nothing. A separate meta-analysis found that saline rinsing cut medicine use by about 60% and improved nasal symptoms by roughly 28%.
Saline irrigation works even better when paired with a steroid spray. A 2025 study found that patients using both saline rinses and intranasal corticosteroids had greater improvements in runny nose, sneezing, and nasal blockage than those using the steroid alone. The rinse physically flushes out allergens and mucus, making it easier for the steroid to reach the nasal lining. Side effects are minimal: occasional nosebleeds or mild discomfort, and in many studies none were reported at all. Using distilled or previously boiled water is important to avoid the very rare risk of infection from tap water.
Montelukast and Why It Is No Longer First Choice
Montelukast (Singulair) blocks leukotrienes, inflammatory chemicals involved in both asthma and allergic rhinitis. It was once widely prescribed for nasal allergies, but its reputation has taken a hit over the past several years. Compared to intranasal steroids and antihistamines, montelukast is generally less effective for nasal symptoms, and it carries a unique safety concern that other allergy drugs do not.
A large database study found that people starting montelukast had roughly 11% to 21% higher odds of being diagnosed with anxiety, insomnia, or other neuropsychiatric conditions within a year, compared to similar patients who were not on the drug. A meta-analysis confirmed about an 11% increased risk of anxiety associated with montelukast use. The FDA added a boxed warning to the drug in 2020, and most guidelines now recommend it only when first-line treatments are inadequate or when a patient also has asthma that benefits from leukotriene blockade.
Eye Allergy Drops
Itchy, watery eyes are one of the most bothersome allergy symptoms, and they don’t always respond well to the same treatments that clear up nasal congestion. Oral antihistamines help somewhat, but topical antihistamine eye drops like olopatadine or ketotifen work faster and more effectively for isolated eye symptoms. A review in the journal Drugs found that ophthalmic antihistamines provide faster and superior relief compared to systemic antihistamines and may also outlast other topical options like vasoconstrictors and mast cell stabilizers.
If your eyes are your main complaint, reaching for eye drops rather than relying solely on a pill or nasal spray makes a real difference. Many people with seasonal allergies find that their nasal steroid handles the nose well but leaves the eyes still bothering them, and adding a topical antihistamine drop fills that gap.
Decongestants and the Rebound Trap
Decongestant nasal sprays containing oxymetazoline or phenylephrine can unstuff a blocked nose within minutes, which makes them feel like miracle products. The problem is that using them for more than a few consecutive days triggers rebound congestion, a condition called rhinitis medicamentosa, where the nasal lining swells even more than it did before you started spraying. Some people end up using the spray compulsively for months or years, unable to breathe without it.
Oral decongestants like pseudoephedrine avoid the rebound problem but raise blood pressure and can cause insomnia and jitteriness. They are best thought of as short-term rescue tools for a bad cold or a particularly brutal allergy day, not as a regular treatment strategy. For sustained congestion relief, the steroid spray remains the better daily option by a wide margin.
Allergen Immunotherapy for Long-Term Control
Every treatment discussed so far manages symptoms without changing the underlying allergy. Immunotherapy is the only approach that can actually retrain your immune system to tolerate what it currently overreacts to. It comes in two forms: subcutaneous injections (allergy shots) given in a doctor’s office, and sublingual tablets or drops placed under the tongue at home. A head-to-head study found both delivery methods to be similarly effective at reducing symptoms and medication use.
The standard course is three years. Evidence suggests that this duration produces immune changes consistent with lasting tolerance that persists for at least two to three years after stopping treatment. For children, the benefits may go further. The PAT study followed children with hay fever who received immunotherapy and found that treated children had significantly less asthma five years later, with the odds of developing asthma roughly 2.7 times higher in the untreated group. European guidelines now recommend a three-year course for children with moderate-to-severe pollen-triggered allergic rhinitis specifically to help prevent asthma onset.
Immunotherapy is not a quick fix. It takes months to build up to a maintenance dose, and the full course runs three years. It works best for well-defined triggers like grass pollen, tree pollen, dust mites, and cat dander. For people whose allergies are severe enough to hurt their quality of life despite medications, or who want to reduce their long-term medication burden, it is the strongest option available.
Food Allergy Treatments
Food allergies operate on different biology than hay fever, and the treatment options are newer and more complex. Oral immunotherapy, which involves eating tiny but gradually increasing amounts of the allergenic food under medical supervision, has shown strong desensitization rates. A systematic review of randomized trials found that OIT significantly increased the chance of tolerating the food across peanut, egg, and milk allergies. However, the treatment itself causes allergic reactions: epinephrine use was roughly two to three times higher in peanut OIT groups compared to placebo, and the rate was even higher for milk.
Omalizumab, an injectable biologic that blocks IgE (the antibody driving allergic reactions), was approved in 2024 for food allergy in people aged one year and older. In a trial of children with multiple food allergies, about two-thirds of those on omalizumab could tolerate a substantial dose of peanut protein after 16 weeks, compared to only 7% on placebo. The drug also raised tolerance thresholds for cashew, milk, and egg. A smaller study in children with severe food allergy found that omalizumab increased the amount of allergenic food tolerated from as little as 13 milligrams up to 44,000 milligrams in some cases.
A newer approach, epicutaneous immunotherapy, delivers allergen through a skin patch rather than through the mouth. A phase 3 trial in toddlers with peanut allergy found that about two-thirds of children wearing the active patch met the efficacy endpoint, compared to a third on placebo. Long-term safety data from a three-year follow-up study showed that local skin reactions were the most common side effect and decreased substantially over time, dropping from about 88% of patients in the first year to 19% by the third year. This patch-based approach may eventually offer a less intimidating entry point for young children, though it is not yet widely available.
HEPA Filters and Environmental Controls
Reducing your exposure to allergens is a common-sense strategy, but how much it helps depends on what you’re allergic to and how thoroughly you control your environment. HEPA air filtration has been shown to meaningfully cut airborne allergen levels indoors. A study measuring allergens before and after filtration found reductions of about 75% for dust mite allergens, 77% for cat allergens, and 89% for dog allergens.
Whether those reductions translate into noticeably better symptoms is a separate question. A double-blind trial of HEPA filters in patients with perennial allergic rhinitis and asthma found no overall difference in symptoms during the active versus placebo filter periods, though a subgroup analysis excluding periods of respiratory infection did suggest benefit, and patients subjectively felt better with the filter running. The honest takeaway is that air filtration helps as part of a broader plan, especially for pet and dust mite allergies, but it is unlikely to replace medication on its own. Think of it as turning the volume down on your allergen exposure rather than muting it.
Biologics and Cost Realities
Biologic drugs like omalizumab and dupilumab represent the frontier of allergy treatment, targeting specific immune pathways with precision. Dupilumab, originally approved for eczema and asthma, has shown favorable outcomes in patients with overlapping allergic conditions, with improved disease control observed in roughly 62% of cases when used in combination therapy. These drugs can be genuinely transformative for people with severe, treatment-resistant allergic disease.
The barrier is cost. An analysis published in the Annals of Allergy, Asthma and Immunology found that pricing for all available asthma biologics exceeded standard cost-effectiveness thresholds, and that prices would need to drop by at least 60% to meet those benchmarks. Quality-of-life improvements, while real, were described as modest relative to the expense. For most people with garden-variety seasonal or perennial allergies, biologics are overkill. They enter the picture when someone has failed multiple conventional treatments, has severe asthma alongside their allergies, or has life-threatening food allergies where the risk-benefit math favors an expensive intervention.
Getting the Diagnosis Right
The best treatment in the world won’t help much if you’re treating the wrong trigger. Standard allergy testing using skin pricks or blood tests for IgE gives you a list of things you’re sensitized to, but it doesn’t always tell you which sensitizations are clinically relevant. Someone who tests positive to ten different pollens may actually be reacting to just two or three, with the other positives reflecting cross-reactive proteins shared between unrelated allergens.
Component-resolved diagnosis, a newer form of blood testing that measures IgE against individual allergenic proteins rather than whole extracts, can sort this out. It helps distinguish genuine multiple allergies from cross-reactivity, predict which food-allergic patients are at risk for severe reactions, and select the right allergens for immunotherapy. This matters because immunotherapy works best when targeted at the patient’s true triggers. If the wrong allergens are chosen based on misleading test results, you end up spending three years on a treatment course that misses the mark. Component testing is not yet routine everywhere, but asking about it is worthwhile if you are considering immunotherapy or if standard testing has left your picture unclear.
Complementary and Alternative Approaches
Plenty of people want to manage allergies without drugs, and a few non-pharmaceutical approaches have at least preliminary evidence behind them. Butterbur (Petasites hybridus) extract has shown some benefit for allergic rhinitis in small trials, and acupuncture has been studied as an add-on therapy for nasal symptoms with mixed but occasionally positive results. Probiotics during pregnancy have been explored for preventing allergic disease in offspring, though the evidence remains early and inconsistent.
The difficulty with most complementary therapies is that the studies tend to be small, short, and hard to compare with one another. None have come close to the evidence base behind intranasal steroids or antihistamines. If you want to try butterbur or acupuncture alongside conventional treatment, the risk is generally low, but replacing proven medications with these approaches entirely is a gamble that the current evidence does not support.